What are the reasons for negative phase III trials of molecular-target-based drugs?
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-10-10
著者
関連論文
- Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
- Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences
- Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
- Fourteen Novel Genetic Variations and Haplotype Structures of the TYMS Gene Encoding Human Thymidylate Synthase (TS)
- Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
- Summary of the ASCO-JSCO Joint Symposium
- Report from the second Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2007 : 'Diagnosis and treatment of urological malignant tumors : How can we promote subspecialists?'
- INHIBITORY EFFECTS OF REPEATED INTRAVENOUS INJECTIONS OF DEXAMETHASONE ON PULMONARY TOXICITY OF A NEW MITOMYCIN C ANALOGUE, KW-2149, IN A NOVEL RAT MODEL
- Inhibitory effects of dexamethasone on pulmonary toxicity of a new mitomycin C analogue KW-2149 in a novel rat model.
- What are the reasons for negative phase III trials of molecular-target-based drugs?
- Translational and clinical studies of target-based cancer therapy
- Summary of the ASCO-JSCO Joint Symposium
- Recent trends in the treatment of advanced lung cancer
- 19.Endpoints for multimodol clinical trials in stage III NSCLC(第108回日本肺癌学会関東支部会)
- Future prospects for the treatment of non small cell lung cancer
- Distal Promoter Regions Are Responsible for Differential Regulation of Human Orosomucoid-1 and -2 Gene Expression and Acute Phase Responses